Projects at NIPER Hyderabad

NIPER Hyderabad lays strong emphasis on the sponsored research, collaborative research funded by the international and national agencies and strong industrial interaction. The institute has set up modern laboratories and the supporting infrastructure. The sponsored research has also emerged as a crucial factor in the creation of the infrastructure while strengthening the facilities in some of the emerging areas of technology.

Sponsored Research Projects :

S.No. Name of Faculty (Principal Investigator) Name of the Funding Agency Title of the Project Sanctioned Order No. Sanctioned Date Amount received (In Rupees)
22 Dr. Neelesh Kumar Mehra (PI)
Dr. Dharmendra Khatri (Co-PI)
Dr. Vivek Singh (Co-PI)
Department of science and technology (DST), New Delhi Development of Novel Eye Drops of fixed dose combination for Effective Ocular Delivery F. No. DST/NM/NS/2021/405 23.06.2021 Rs. 29,20,000
21 Dr. Neelesh Kumar Mehra (PI)
Dr. Dharmendra Khatri (Co-PI)
Dr. Pankaj K Singh (Co-PI)
Central Council of Research in Unani Medicine (CCRUM), New Delhi India Pharmacological activities and pre-clinical screening of the promising unani medicines against hepatic disease F. No. 3-12/2021-CCRUM/Tech 23.06.2021 Rs. 24,53,360
20 Dr. Saurabh Srivastava NBI, Gurugram Development and evaluation of oral drug delivery systems for colon targeting of drugs for the local & systemic actions NBI/R&D/SLIDD/011 10.04.2021 8.26 Lakhs
19 Dr. Manoj P. Dandekar Unique Biotech To study the effect of selective probiotics with glutamine on depression-like phenotype in Sprague-Dawley rats NA 20.11.2020 1,50,000
18 Dr. Manoj P. Dandekar DST-SERB Role of age- and sex-specific gut microbiota in brain injury for microbiome-based therapeutics SRG/2020/002439 05.10.2020 32,69,512
17 Dr. Santosh Kumar Guru DST-SERB Analysis of the role of extracellular vesicles (Exosomes) in drug tolerant persister cells and its contribution to cancer initiating cells in breast cancer SRG/2020/002013 17.03.2021 21,89,000
16 Dr. Dharmendra K. Khatri NBI Biosciences Pvt. Ltd, Gurgaon, India. In vitro screening of Dopamine decarboxylase (DDC) inhibition potential and Blood brain barrier (BBB) status of plant-based molecules NA 16.11.2020 6,17,249
15 Dr. Dharmendra K. Khatri NBI Biosciences Pvt. Ltd, Gurgaon, India. To study the efficacy of therapeutic plant molecule in animal models to treat Chronic Obstructive Pulmonary Disease (COPD) by the lung regeneration/repair process File no: NBI/R&D/COPD/03 12.05.2021 16,67,930
14 Dr Saurabh Srivastava and Dr Neelesh Kumar Mehra DRL, DRDO, Tezpur, India Development, Evaluation and Characterization of Hydrophobic Nanoparticles Impregnated Fabrics to be Assessed as Dress Material For Defense File no: DRL/1205/TC 03-11-2020 9.9 Lakhs
13 Dr Neelesh Kumar Mehra
Dr Chandraih Godugu
CCRUM, New Delhi Formulation, Development, Evaluation and Assessment of Safety and toxicity of Unani Herbal toothpaste (Sunoon-e-Mustahkam-e-Dandan) File no: ........ 07-10-2020 04,50,000
12 Dr. Y.V. Madhavi -- Development of scalable, safe and cost effective process for the API of Umifenovir (Arbidol) a promising repurposed drug for COVID-19 in India File no: ........ 22/01/2021 10,00,000
11 Dr. Ashutosh Kumar CCRUM, New Delhi Preclinical Evaluation of UNIM-401 and UNIM-403 for Psoriasis and UNIM-404 and UNIM-405 for vitiligo File no: ........ 08/09/2019 58,00,000
10 Dr. Y.V Madhavi Life Sceinces Research Board (LSRB), DRDO Development of a scalable route for the manufacture of Prussian Blue insoluble of pharmaceutical grade, an FDA approved decorporation drug File no: LSRB-344/SH&DD/2019 13/06/2019 49,76,640
9 Dr. S. Gananadhamu DST-SERB-EMEQ Studying the role of reactive impurities in excipients on the formation of degradation products with genotoxic potential File no: EEQ/2018/001461 22/02/2019 32,39,000.00
8 Dr. Md. Arifuddin & Dr. M. Mallika DBT Design and Development of novel antitubercular agents targeting Shikimate Kinase protein File No: BT/PT23619/MED/29/1199/2017 09/01/2018 Rs. 46,55,000
7 Dr Nanduri Srinivas SERB - Extra Mural Project Synthesis and therapeutic evaluation of new LpxC inhibitors as potent anti- bacterial agents File No: EMR/2017/000220 12/05/2017 Rs. 43,00,000
6 Dr Chandraiah Godugu DST-DAAD Targeting Lysyl Oxidase-2 and miRNA for Effective Gene Therapy of Liver fibrosis DST/INT/FRG/DAAD/P-01/2017 12/07/2017 Rs. 19,90,000
5 Dr. Ashutosh Kumar DST (EMR project) Evaluation of neuroprotective effects of AMPK & SIRT1 modulation in experimental diabetic neuropathy using pharmacological approaches File No: EMR/2016/006258 20/04/2017 Rs. 46,00, 000
4 Dr. Ashutosh Kumar DST (indo-poland) collaboration Evaluation of Anti-Glycation and Antioxidant Properties of Natural Polyphenolic Compounds in Experimental Models of Diabetic Complications. File No: DST/INT/Pol/P-30/2016 04/01/2017 Rs. 22,00, 000
3 Dr. N. Satheesh Kumar DST- SERB-EMR Herb - Drug Interactions: Transport and Metabolism of herbal slimming agents in the presence of lipase inhibitors, antihyperglycemic agents, HMG-CoA reductase inhibitor and hypocholesterolemic agent File No: EMR/2016/002098 24/01/2017 Rs. 51,57, 585
2 Dr. T. D. Neelima DST Polycyclic 1,4-Benzoxazines via Oxidative Dearomatization and Intramolecular aza-Michael and aza-Diels-Alder Cyclization. Synthesis Of Levofloxacin 2017 Rs. 36,00,000
1 Dr. M. Mallika DBT, India Discovery of non-carbohydrate selective inhibitors of the galectin-1 for the treatment of cancer File No: 6242-19/RGCB/PMD/DBT/MLKA/2015 24/05/2017 Rs.5,69,190.00

Consultancy Projects at the Institute:

The NIPER Hyderabad has expertise in various research areas to provide knowledge and intellectual inputs which are of interest to the industry and other organisations.

Consultancy Projects in the year 2017:

S.No. Name of Faculty (Principal Investigator) Name of the Funding Agency Title of the Project Sanctioned Order No. Sanctioned Date Amount received (In Rupees)
1 Dr.M.Mallika M/S ISSAR Pharma Pvt Ltd, Hyderabad Bioinformatics work 2017 Rs. 283500